Literature DB >> 3181686

Effects of intraluminal prostaglandin E2 in vivo on secretory behavior and ultrastructural changes in mouse gallbladder epithelium.

T Wahlin1, E Thornell, L Jivegård, J Svanvik.   

Abstract

It has been suggested that glycoproteins play an important role as a nucleating agent in the pathogenesis of gallstone formation. Arachidonic acid, by an indomethacin-sensitive mechanism, is known to enhance gallbladder mucus release, suggesting that prostaglandins may regulate gallbladder epithelial release of mucus. In this study, the glycoprotein granules of the principal cells of the mouse gallbladder epithelium were morphometrically analyzed using electron microscopy. It was shown that 5 micrograms of prostaglandin E2, injected into the gallbladder lumen of the anesthetized mouse, reduced the relative volume of glycoprotein granules from 3.0% to 0.7% of the cytoplasmic volume within 20 min, whereas injection of the same amount of the solvent for prostaglandin E2 had no such effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181686     DOI: 10.1016/s0016-5085(88)80088-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  4 in total

Review 1.  Interactions between gall bladder bile and mucosa; relevance to gall stone formation.

Authors:  M R Jacyna
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

2.  Evidence of hydrogen ion secretion from the human gall bladder in vitro.

Authors:  J N Plevris; P C Hayes; D J Harrison; I A Bouchier
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Inflammatory cytokines alter human gallbladder epithelial cell absorption/secretion.

Authors:  R V Rege
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

4.  Role of cytosolic phospholipase A2 in cytokine-stimulated prostaglandin release by human gallbladder cells.

Authors:  E M Grossmann; W E Longo; J E Mazuski; N Panesar; D L Kaminski
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.